SEARCH

Practice Administrator Resume Example

Resume Score: 80%

Love this resume?Build Your Own Now
PRACTICE ADMINISTRATOR
Summary

Effective at improving revenue, team productivity and policies to keep the facility operating at a sustainable and profitable level. Well-versed in motivating and retaining employees, building relationships with patients health insurances and vendors and families and achieving the requirements for continued accreditation. Passionate professional able to adapt quickly to new and changing environments. Natural capacity to lead or contribute to a team. Impeccable work ethic and success in developing a diverse client base.

Skills
  • Schedule management
  • Records maintenance
  • Personnel management
  • Census goals
  • Patient relations
  • Quality assurance controls
  • Facility oversight
  • Health information systems
  • Records management
  • Staff supervision
  • Healthcare delivery
  • Patient safety
  • Organizational skills
  • Accreditation support
  • Regulatory requirements
  • Performance metrics
  • Billing
  • MRA
  • Utilization Management
  • Credentialing
  • Contract Negotiation
  • Clinical Research
  • Business Development
Experience
Company NameCity, StatePractice Administrator11/2015 to Current
  • Researched health center standards and guidelines to identify best practices and improvement opportunities.
  • Improved clerical infrastructure by implementing medical content management system.
  • Trained front desk receptionist to enthusiastically greet and assist incoming patients.
  • Represented company professionally when engaging with public and government agencies.
  • Responded proactively to concerns and questions by acting on patient feedback.
  • Satisfied customer queries over phone and email to maintain positive patient-provider relationships.
  • Created documentation to articulate departmental roles and drafted statement-of-work for each team.
  • Implemented cost control policies to limit excessive or unmanaged spending by various teams.
  • Archived all correspondence with internal staff and external partners to answer potential future inquiries.
  • Prepared, verified and distributed Financial reports to valid parties after identifying identity and right to access.
  • Recruited and hired intelligent clinical and administrative staff to bolster skills set of already talented team.
  • Ordered all supplies needed for the pharmacy and kept tabs on inventory levels.
  • Communicated with patients with compassion while keeping medical information private.
  • Diversified facility offerings by adding services such as DME, medication dispensing, regenerative medicine services, research studies.
  • Collaborated with multi-disciplinary staff to improve overall patient care and response times.
  • Supervised administrative staff of 30 Physicians, Mid-level practitioners, Registered, X-ray technicians, medica assistants, research coordinators and billers delivering consistent coaching and mentoring to improve job efficiency.
  • Created and maintained facility documents and records, maintaining accuracy while managing sensitive data.
  • Implemented new hire training to further develop skills and initiate discussions on task prioritization.
  • Credential, licensing and contract negotiations.
  • Clinical research, pharmaceutical trial experience.
  • Responsible for outstanding performance in MIPS.
  • MRA, Billing and coding, HEDIS/STARS, utilization management
  • Marketing
Company NameCity, StateUtilization Manager11/2013 to 11/2015
  • Applied medical criteria and clinical judgement to researched cases to evaluate and establish determinations.
  • Collaborated with providers to obtain required clinical information, supporting prior authorization determinations and individual inquiries.
  • Collaborated with case managers and MRA coders in group meetings to identify issues and find cost-effective solutions.
  • Remained up-to-date on various benefit plans, medical policies and state-specific clinical guidelines or criteria.
  • Managed the authorization department and billing department processes pertaining to denials and potential denials as outlined by insurance carriers.
  • Reviewed patient admissions to determine medical necessity.
  • Determined medical necessity and cost-effectiveness of services through utilization review processes.
  • Kept detailed documentation on all utilization reviews by using Eclinical works .
  • Executed strategies to foster better customer service and promote positive and engaging environment for all.
  • Reviewed employee performance every 180 days and yearly and delivered constructive feedback to improve weaknesses.
  • Eliminated process discrepancies, implementing continuous improvements for scheduling procedures across multiple client calendars.
  • Collaborated with CEO and COO to present insurance alternatives as part of comprehensive financial plans.
  • Studied existing procedures and policies to offer optimal leadership to employees and operations when standing in for absent managers.
  • Interacted with prospects patients at various marketing events during open enrollment season and all year round.
  • Leveraged market knowledge and leadership ability to help drive profit increases.
  • Improved productivity initiatives, coordinating itinerary and scheduling appointments.
  • Strengthened operational efficiencies and traceability, developing organizational filing systems for confidential client records and reports.
  • Remained calm and professional in stressful circumstances and when dealing with unhappy patients and physicians, effectively diffusing situations.
Company NameCity, StatePractice Manager of Operations06/2005 to 11/2013
  • Motivated staff by offering direction and providing constructive feedback.
  • Consulted with clinicians to develop business strategy.
  • Developed and implemented policies and procedures for the facility.
  • Coordinated financial operations, including budgeting, accounting, expenses and financial reporting.
  • Supported the entire practice's staff, which boosted efficiency and improved the overall process flow.
  • Communicated with patients with compassion while keeping medical information private.
  • Assisted with the development of regulatory compliance systems.
  • Created and implemented policies and procedures for effective practice management.
  • Created and maintained electronic record management (EMR) systems to store data and develop reports.
  • Complied with OSHA and HIPAA regulations.
  • Supervised administrative staff, physicians ans nurses, delivering consistent coaching and mentoring to improve job efficiency.
  • Collaborated with multi-disciplinary staff to improve overall patient care and response times.
  • Worked closely with store manager to maintain day-to-day operations.
  • Recruited and hired intelligent clinical and administrative staff to bolster skills set of already talented team.
  • Reviewed and assessed staff processes, reducing hazards posed for residents and staff while promoting regulatory compliance.

Education and Training
Some College (No Degree):Health Care Administration Everest University - Orlando, City
Diploma :Medical Assistant Everest University - Orlando, City
Clinical Research Pharmaceutical Clinical Trial Experience

· Clinical Protocol FX006-2018-016: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis.

· Clinical Protocol A7005: PRO Study: A Study to Characterize Real-World Clinical Outcomes of Spinal Cord Stimulation (SCS) Using Retrospective Review of De-Identified Patient Records.

· Clinical Protocol 1237-0064: Randomization Pragmatic Clinical Trial in a Community Based Setting Comparing Stiolto Respimat vs. ICS-Laba Plus Lama in Patients with COPD

· Clinical Protocol A7007: ENVISION Study: A Study to Characterize the Relationship Between Selective Metrics and Clinical Outcomes in Chronic Pain Patients Treated with Boston Scientific Commercially Approved Neurostimulations Systems and may use Observed Relationships to make Recommendations

· Clinical Protocol AXS-07-301: A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (meloxicam and rizatriptan) for the Acute Treatment of Migraine in Adults

· Clinical Protocol A4070: Study to Demonstrate the Value of Multiple Modalities and Combining Mechanisms using the Spectra WaveWriter Spinal Cord Stimulator System in the Treatment of Chronic Pain

· Clinical Protocol 2015-DFU-301: A Phase 3, Randomized, Double-blind, Parallel-group, Vehicle controlled, Multicenter Study of the Efficacy and Safety of Granexin Gel in the Treatment of Diabetic Foot Ulcer

· Clinical Protocol 6603/1133: A Multicenter, Randomized, Double-blind, Cham-controlled, Comparative Study of SI-6603 in Subjects with Lumbar Disc Herniation (Phase 3)

· Clinical Protocol RPC01-3202: Induction Study #2: A Phase 3 Multicenter Randomized, Double -Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease.

· Clinical Protocol RPC01-3203: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease.

· Clinical Protocol RPC01-3204: A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease.

· Clinical Protocol M16-006: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease

· Clinical Protocol M15-991: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

· Clinical Protocol M16-000: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991

· Clinical Protocol M16-066: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis Who Responded to Induction Treatment in M16-067 or M16-065.

· Clinical Protocol M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy.

· Clinical Protocol SKK 6603/1133: A Multicenter, Randomized, Double-blind, Sham-controlled, Comparative Study of SI-6603 in Subjects with Lumbar Disc Herniation (Phase 3).

· Clinical Protocol AXS02-301 CREATE-1 Sub- Study: CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects.

· Clinical Protocol KF7013-04: Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

· Clinical Protocol IBD-600: Corrona Inflammatory Bowel Disease Registry

· Clinical Protocol UCB RA0098 / PXL # 225110: A Multicenter, Open-Label Study to Evaluate the Safe and Effective Use Of An Electro-Mechanical Injection Device (E-Device) For The Subcutaneous Self-Injection Of Certolizumab Pegol Solution by Subjects with Moderate To Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Asthritis, or Moderately to Severely Active Crohn's Disease.

· BWH1-12-468: A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome

· Clinical Protocol A7007: NAVITAS Study: A Study to Evaluate the Effect of Boston Relief SCS Systems on Auxiliary Objective Metrics for Pain. (A sub-study of the Boston RELIEF sub-study).

· Clinical Protocol AXS02-K301: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS02 (Disodium Zoledronate Tetrahydate) Administered Orally to Subjects with Knee Osteoarthritis Associated with Bone Marrow Lesions.

· Clinical Protocol MTV-601-3001: Liberty 1- An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women and Heavy Menstrual Bleeding Associated with Uterine Fibroids.

· Clinical Protocol MVT-601-3101: SPIRIT 1 - An International Phase 3 Randomized, Double-Blind, Placebo Controlled Efficacy and Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Endometriosis-Associated Pain

· Clinical Protocol A7007: Boston RELIEF Study: A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain.

· Clinical Protocol CR 845-CLIN-3001: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating The Analgesic Efficacy & Safety of Intravenous CR-845 In Patients Undergoing Abdominal Surgery.

· Clinical Protocol KF7013-03: Open-Label Safety Trial of Intravenous Neridronic Acid in Subjects with Complex Regional Pain Syndrome (CRPS)

· Clinical Protocol AXSO2-301: CREATE-1 Study CRPS Treatment Evaluation 1 Study A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional Pain Syndrome Type 1 (CRPS-1)

· Clinical Protocol INN-CB-014: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the Xaracoll Bupivacaine Implant (300mg Bupivacaine Hydrochloride) After Open Laparotomy Hernioplasty

· Clinical Protocol INN-TOP-004: A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination with Systemic Antibiotic Therapy in Diabetic Patients with an Infected Foot Ulcer

· Clinical Protocol 6603/1132: A Multicenter, Open-Label Study of SI-6603 in Patients with Lumbar Disc Herniation. (Phase III)

· Clinical Protocol 6603/1131: A Multicenter, Randomized, Double-blind, Controlled, Comparative Study of SI-6603 in Patients with Lumbar Disc Herniation (Phase III)

· Clinical Protocol KF7013-01: A Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

· Clinical Protocol AMG334: A Prospective, Observational Study for the Psychometric Evaluation of a Novel Migraine-Related Functional Impact Instrument in Episodic and Chronic Migraines.

Build Your Own Now

DISCLAIMER

Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.

Resume Overview

School Attended

  • Everest University - Orlando

Job Titles Held:

  • Practice Administrator
  • Utilization Manager
  • Practice Manager of Operations

Degrees

  • Some College (No Degree) : Health Care Administration
    Diploma : Medical Assistant

Similar Resumes

View All
Practice-Administrator-resume-sample

Practice Administrator

Pompano Beach, Florida